What is the share price of Sanofi-Synthelabo (India) Ltd. - (Amalgamated)?

Company share prices are keep on changing according to the market conditions. The current trading price of Sanofi-Synthelabo (India) Ltd. - (Amalgamated) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Sanofi-Synthelabo (India) . - (Amalgamated)?

The latest standalone P/E ratio of Sanofi-Synthelabo (India) . - (Amalgamated) as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Sanofi-Synthelabo (India) Ltd. - (Amalgamated)?

The latest standalone P/B ratio of Sanofi-Synthelabo (India) Ltd. - (Amalgamated) as of 01-Jan-1970 is 0.00.

What is the 52-week high and low of Sanofi-Synthelabo (India) Ltd. - (Amalgamated)?

The 52-week high of Sanofi-Synthelabo (India) Ltd. - (Amalgamated) is Rs. and the 52-week low is Rs. .

Sanofi-Synthelabo (India) Ltd. - (Amalgamated)

Name: Sanofi-Synthelabo (India) Ltd. - (Amalgamated)
Brand: Sanofi-Synthelabo (India) . - (Amalgamated)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Pharmaceuticals & Drugs | Small Cap | Sanofi-Synthelabo (India) Ltd. Share Price

BSE Share Price
Not Listed

Sanofi-Synthelabo (India) Ltd. - (Amalgamated)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Pharmaceuticals & Drugs | Small Cap | Sanofi-Synthelabo (India) Ltd. Share Price

BSE Share Price
Not Listed

Key Metrics

Valuation Multiples

Market Cap

₹0 Cr.

Current Price

₹0

52-Week Low / High

₹0 / 0

TTM EPS

TTM Sales

Book Value per Share

P/E Ratio

Industry PE

54.2

Price to Book (P/B)

Price to Sales (P/S)

EV/EBITDA

Dividend Yield

NAN%

Profitability Efficiency

Return on Equity (ROE)

10.31%

Return on Capital Employed (ROCE)

17.39%

Return on Assets (ROA)

5.93%

Operating Profit Margin

12.6%

Net Profit Margin

8.29%

Gross Profit Margin

15.9%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

10.85%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

-4.79%

Net Profit Growth (1 Year)

Slowing versus 3-year growth rate

-9.03%

Asset Quality

Promoter Holding

Pledged shares (%) of Promoter's holding (%)

Reserves

Equity

₹0 Cr.

Face Value

₹10

All Time Low / High

- / -

Sanofi-Synthelabo (India) . - (Amalgamated) stock performance

Key Ratios

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	TTM
ROCE % ⓘ	47.1%	48.5%	46%	43.5%	2.8%	-12.8%	2.8%	46.4%	19.5%	15.6%	-
Value Creation Index ⓘ	2.4	2.5	2.3	2.1	-0.8	-1.9	-0.8	2.3	0.4	0.1	-
Growth Parameters ⓘ
Sales ⓘ	186	216	243	327	355	409	428	536	547	607	607
Sales YoY Gr.	-	16.1%	12.5%	34.3%	8.8%	15%	4.6%	25.3%	2.2%	10.9%	-
Adj EPS ⓘ	10	13.3	17.5	22.6	1.6	-3.6	1.1	6.2	15	13	0
YoY Gr.	-	34.1%	31.5%	29%	-92.8%	-322.1%	NA	484%	142.7%	-13.6%	-
BVPS (₹) ⓘ	34.8	48.3	66	88.8	90.4	92.8	94.2	126	142.2	154.7	0
Adj Net Profit ⓘ	27.9	37.4	49.1	63.4	4.6	-12	3.5	20.5	49.8	43	0
Cash Flow from Ops. ⓘ	26.1	44.1	51.7	53.1	20.7	68.4	64.5	152	42	64.7	-
Debt/CF from Ops. ⓘ	0	0	0	0	0	0	0	0	0	0	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	14%	11.3%	12.4%	10.9%
Adj EPS ⓘ	3%	51.4%	130.5%	-13.6%
BVPSⓘ	18%	11.3%	18%	8.8%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	TTM
Return on Equity % ⓘ	33.3	32.1	30.7	29.2	1.8	-4.3	1.1	5.6	11.1	8.6	0
Op. Profit Mgn % ⓘ	26.1	27.5	29.2	26.3	10.1	16.5	1.3	8.2	14.5	11.3	NAN
Net Profit Mgn % ⓘ	15	17.3	20.2	19.4	1.3	-2.9	0.8	3.8	9.1	7.1	0
Debt to Equity ⓘ	0	0	0	0	0	0	0	0	0	0	-
Working Cap Days ⓘ	83	81	142	119	98	104	100	86	170	245	0
Cash Conv. Cycle ⓘ	18	-6	-7	-16	19	30	-5	-7	25	17	0

Valuation of Sanofi-Synthelabo (India) Ltd. - Consolidated

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Management X-Ray

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Financials

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19
Sales	427.57	535.67	547.25	606.64
Operating Expenses ⓘ +	421.99	491.53	468.05	531.23
Manufacturing Costs	36.93	39.43	96.32	90.12
Material Costs	87.64	93.06	162.75	205.09
Employee Cost	47.15	56.09	64.35	70.61
Other Costs ⓘ	250.27	302.95	144.63	165.41
Operating Profit ⓘ	5.58	44.14	79.20	75.41
Operating Profit Margin (%)	1.3%	8.2%	14.5%	12.4%
Other Income ⓘ +	10.07	11.62	21.10	21.57
Exceptional Items ⓘ	0	122.97	5.77	0
Interest ⓘ	0	0	0	0.46
Depreciation ⓘ	6.98	8.93	19.04	11.03
Profit Before Tax ⓘ	8.67	169.80	87.03	85.49
Tax ⓘ	3.95	63.22	31.74	35.19
Profit After Tax	4.72	106.58	55.29	50.30
PAT Margin (%)	1.1%	19.9%	10.1%	8.3%
Adjusted EPS (₹)	0.4	31.5	16.2	15.2
Dividend Payout Ratio (%)	0%	0%	0%	0%

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19
Equity and Liabilities
Shareholders Fund +	308	411.28	463.03	512.76
Share Capital ⓘ	33.14	33.14	33.14	33.14
Reserves ⓘ	274.86	378.14	429.89	479.62
Debt +	0	0	0	0
Long Term Debt	0	0	0	0
Short Term Debt	0	0	0	0
Minority Interest	0	0	0	0
Trade Payables	49.94	48.06	72.23	96.84
Others Liabilities ⓘ	12.39	45.32	256.07	295.42
Total Liabilities ⓘ	370.33	504.66	791.33	905.02
Fixed Assets
Net Fixed Assets ⓘ +	33.46	82.94	78.93	74.20
Gross Block	288.61	91.87	106.90	112.81
Accumulated Depreciation	255.15	8.93	27.97	38.61
CWIP ⓘ	0.50	8.56	1.27	1.90
Investments ⓘ	51.97	20.18	18.40	0
Inventories	51.83	69.69	58.86	71.53
Trade Receivables	47.98	41.24	82.04	73.95
Cash Equivalents ⓘ	162.77	259.18	314.21	392.17
Others Assets ⓘ	21.82	22.87	237.62	291.27
Total Assets ⓘ	370.33	504.66	791.33	905.02

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19
Cash Flow From Operating Activity ⓘ +	64.50	151.56	42.03	64.70
PBT ⓘ	91.56	184.36	87.03	85.49
Adjustment ⓘ	-16.21	-15.36	26.74	19.88
Changes in Working Capital ⓘ	6.5	-8.46	-34.19	2.51
Tax Paid ⓘ	-17.35	-38.62	-37.55	-43.18
Cash Flow From Investing Activity ⓘ +	3.52	-55.15	12.52	13.26
Capex	-4.21	-66.44	-7.94	-8.08
Net Investments	0	0	0	0
Others ⓘ	7.73	11.29	20.46	21.34
Cash Flow From Financing Activity ⓘ +	0	0	0	0
Net Proceeds from Shares ⓘ	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0
Interest Paid ⓘ	0	0	0	0
Dividend Paid ⓘ	0	0	0	0
Others ⓘ	0	0	0	0
Net Cash Flow ⓘ	68.02	96.41	54.55	77.96

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19
Ratios
ROE (%)	1.53	29.64	12.65	10.31
ROCE (%)	2.81	47.12	19.78	17.39
Asset Turnover Ratio	1.18	1.25	0.85	0.72
PAT to CFO Conversion(x)	13.67	1.42	0.76	1.29
Working Capital Days
Receivable Days	40.20	29.90	41	46.90
Inventory Days	43.40	40.70	42.70	39.20
Payable Days	208	192.20	134.90	150.50

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Sanofi-Synthelabo (India) Ltd. - (Amalgamated) FAQs

The current trading price of Sanofi-Synthelabo (India) Ltd. on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Sanofi-Synthelabo (India) Ltd. stood at ₹0.00 Cr

The latest P/E ratio of Sanofi-Synthelabo (India) Ltd. as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Sanofi-Synthelabo (India) Ltd. as of 31-Dec-1969 is 0.00.

The 52-week high of Sanofi-Synthelabo (India) Ltd. is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Sanofi-Synthelabo (India) Ltd. is ₹607 ( Cr.) .

Data is not available for this company.

No data found

About Sanofi-Synthelabo (India) Ltd. - (Amalgamated)

No data to display

You have 38 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Sanofi-Synthelabo (India) Ltd. - (Amalgamated)

Sanofi-Synthelabo (India) Ltd. - (Amalgamated)

Sanofi-Synthelabo (India) . - (Amalgamated) stock performance

10 Year X-Ray :